Effects of stress on muscarinic mechanisms

Neuroscience and Biobehavioral Reviews

Volumn 12, Issue 1, 1988, Pages 23-28

  Dilsaver, Steven C ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Acetylcholine; Anxiety; Cholinergic; Depression; Mania; Monoamines; Muscarinic mechanisms; Stress

Indexed keywords

MONOAMINE; MUSCARINIC RECEPTOR;

ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANXIETY; CHOLINERGIC SYSTEM; DEPRESSION; HUMAN; HUMAN EXPERIMENT; MANIA; NONHUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; STRESS;

ANIMAL; DEPRESSION; HUMAN; RECEPTORS, MUSCARINIC; STRESS, PSYCHOLOGICAL; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024157599     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(88)80070-8     Document Type: Article

References (93)

1. Induction of the intermediate pituitary by stress: Synthesis and release of nonopioid form of Beta-endorphin
2. The dexamethasone suppression test in depression schizophrenia and during experimental stress
3. Chronic and non-chronic unipolar depression: The differential role of environmental stressors
4. Centrally induced pressure responses to intravenous and intraventricular physostigmine evoked via different pathways
5. Reduction of blood pressure in spontaneous hypertensive rats by atropine and intracerebroventricular injection of hemicholinium-3
6. Cardiovascular control by cholinergic mechanisms in the central nervous system
7. In vitro regulation of ACTH release from neurointermediate lobe of rat hypophysis. II. Effect of the neurotransmitter
8. Rapid eye movement sleep characteristics during and after mood disturbing events
9. Biological stress responses in high and low trait anxious students
10. Cholinergic mechanisms in affective disorders: Future directions for investigation
11. Cholinergic hypothesis of depression
12. Pathophysiology of “cholinoceptor supersensitivity” in affective disorders
13. Cholinergic-monoaminergic interaction in the pathophysiology of affective disorders
14. Cholinergic-monoaminergic systems, depression and panic
15. Antidepressant withdrawal-induced activation (hypomania and mania): Mechanisms and theoretical significance
16. Stress induces supersensitivity of a cholinergic system in rats
17. 3H]quinuclidinyl benzilate binding in the striatum of rats following chronic cholinesterase inhibition with diisopropylfluorphosphonate
18. The nature of muscarinic binding
19. Cholinergic muscarinic receptors in rat cerebral cortex basal ganglia and cerebellum undergo rapid and reversible changes after acute stress
20. Levels and sources of stress in medical students
21. Neurotransmitters in pituitary function: Regulation of ACTH secretion
22. Administration of an organophosphate causes a decrease in muscarinic receptor levels in rat brain
23. Stress-induced activation of the hippocampal cholinergic system and the pituitary adrenal axis
24. Direct adrenergic and cholinergic stimulation of hypothalamic mechanisms
25. Corticotropin and vasopressin secretion after hypothalamic implantation of atropine
26. Corticotropin release: Inhibition by intrahypothalamic implantation of atropine
27. Imipramine and REM sleep: Cholinergic mediation in animals
28. Physostigmine induction of REM sleep in imipramine treated rats
29. The effects of various putative neurotransmitters on the release of corticotropin releasing hormone from the hypothalamus of the rat in vitro. I. The effect of acetylcholine and noradrenaline
30. The reciprocal interaction model of sleep cycle control: Discussion in the light of Giuseppe Moruzzi's concepts
31. The cellular basis of sleep cycle control
32. Spontaneous discharge rats of rat cerebellar purkinje cells in sleep and waking
33. Selective firing by cat pontine brain stem neurons in desynchronized sleep
34. Sleep cycle oscillation: Reciprocal discharge by two brain-stem neuronal groups
35. Acetylcholine and depression
36. Cholinomimetic and anticholinergic drugs used to investigate an acetylcholinal hypothesis of affective disorders and stress
37. An acetylcholine hypothesis of stress modulation
38. Central physostigmine-induced cardiovascular and behavioral changes: Toward an acetylcholine hypothesis of stress
39. Hypothalamic-pituitary-adrenal regulation: Neurotransmitters and affective disorders
40. Effects of physostigmine on pulse, blood pressure and serum epinephrine levels
41. Behavioral effects of physostigmine in affective disorder patients
42. Increased vulnerability to cholinergic stimulation in affective disorder patients
43. Physostigmine-induced epinephrine release in patients with affective disorders
44. Academic stress, power motivation and decrease in secretion rate of salivary secretory immunoglobulin A
45. Neurotransmitter regulation of corticotropin-releasing factor in vitro
46. Cholinergic mechanisms and sleep
47. Paradoxical sleep. A study of its nature and mechanisms
48. Analysis of the inhibition of ACTH release by hypothalamic implants of atropine
49. Enhanced piolcarpine miosis in depressed patients
50. Life events precipitating mania
51. Urinary cortisol levels, cellular immunocompetency, and loneliness in psychiatric patients
52. Circadian pattern of plasma 17-hydroxycorticosteroid: Alteration by anticholinergic agents
53. Panic disorder and major depression
54. The subjective response of psychoneurotic patients to adrenaline and mecolyl
55. Life events and depressive disorder: II. Events as precipitating factors
56. Cholinergic and adrenergic interactions in the thermoregulatory centers of the rat
57. Hypothermia following systematic and intracerebral injection of oxotremorine in the rat
58. The neurochemical basis of REM sleep: A cholinergic mechanisms responsible for rhythmic activation of the vestibuolooculomotor system
59. REM sleep and depression—common neurobiological control mechanisms
60. Single neuron activity in cat gigantocellular tegmental field: Selectivity of discharge in desynchonized sleep
61. Role of adrenergic and cholinergic structures in the control of pituitary-adrenal system
62. Hypothalamic chemoreactive structures and the regulation of pituitary-adrenal function. Effects of local injections of norepinephrine, carbacol and serotonin into the brain of guinea pigs with intact brains and after mesencephalic transaction
63. Post-partum depression: A role for social network and life stress variables
64. Telenephalo-diencephalic aspects of sleep mechanisms
65. Loss-induced depression in an adult Macaque monkey
66. Beta-endorphin hypersecretin in depression: Possible cholinergic mechanisms
67. Mood and behavioral effects of physostigmine on humans are accompanied by elevations in plasma beta-endorphin and cortisol
68. Physostigmine induction of depressive symptomatology in normal human subjects
69. Neuroendocrine abnormalities in affective disorders: Possible cholinergic mechanisms
70. Cholinergic challenges in affective illness: Behavioral and neuroendocrine correlates
71. 3H]quinuclydinyl benzilate associated with low acetylcholinesterase activity
72. Suppression of lymphocyte stimulation following bereavement
73. Presynaptic muscarinic receptors
74. Regulation of muscarinic acetylcholine receptor concentration in cloned neuroblastoma cells
75. Cholinergic activity regulates muscarinic receptors in central nervous system cultures
76. The time dependent induction of REM sleep and arousal by physostigmine infusion during normal human sleep
77. Scopolamine-induced muscarinic supersensitivity in normal man: Changes in sleep
78. Cholinergic regulation of mood and REM sleep: Potential model and marker of vulnerability to affective disorder
79. Faster cholinergic REM sleep induction in euthymic patients with primary affective illness
80. REM sleep induction by physostigmine infusion during sleep
81. Correlation between acetylcholinesterase activity in guinea pig iris and pupillary functions: A biochemical and pupillographic study
82. Antidepressant induced sexual dyfunction in males: Due to cholinergic blockade?
83. Life events and onset of affective disorder: A longitudinal general population study
84. Adrenocortical secretion in response to pilocarpine in dogs with hypothalamic lesions
85. Cholinergic agonists
86. Effective of age on fever and acute-phase response of rats to endotoxin and Salmonella typhimurium
87. Behavioral depression produced by an uncontrollable stressor: Relationship to norepinephreine, dopamine and serotonin levels in various regions of rat brain
88. Regional adaptation of muscarinic receptors and choline uptake in brain following repeated administration of diisopropylfluorophosphonate and atropine
89. Corticotropin-releasing factor stimulation of adrenocorticotropin and Beta-endorphin release: Effects of acute and chronic stress